{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:06:45Z","timestamp":1790388405570,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T00:00:00Z","timestamp":1704585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ihj.2024.01.006","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T02:05:18Z","timestamp":1704852318000},"page":"S138-S140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"S1","title":["Non adherence to lipid-lowering therapy and strategies to improve adherence"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3135-7303","authenticated-orcid":false,"given":"Ashwani","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"39","key":"10.1016\/j.ihj.2024.01.006_bib1","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ihj.2024.01.006_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jvs.2008.04.057","article-title":"Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study","volume":"48","author":"Al-Omran","year":"2008","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.ihj.2024.01.006_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191817","article-title":"Patient-reported adherence to statin therapy, barriers to adherence, and perceptions of cardiovascular risk","volume":"13","author":"Fung","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ihj.2024.01.006_bib4","doi-asserted-by":"crossref","first-page":"i6334","DOI":"10.1136\/bmj.i6334","article-title":"Statins for primary prevention of cardiovascular disease","volume":"355","author":"Otto","year":"2016","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ihj.2024.01.006_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7326\/M14-0126","article-title":"Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology\/American Heart Association cholesterol guideline","volume":"160","author":"Stone","year":"2014","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ihj.2024.01.006_bib6","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1185\/03007990802469102","article-title":"Statin discontinuation: an underestimated risk?","volume":"24","author":"Tziomalos","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"33","key":"10.1016\/j.ihj.2024.01.006_bib7","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.2174\/138161211798220891","article-title":"Statin discontinuation in high-risk patients: a systematic review of the evidence","volume":"17","author":"Gomez Sandoval","year":"2011","journal-title":"Curr Pharmaceut Des"},{"issue":"9","key":"10.1016\/j.ihj.2024.01.006_bib8","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients","volume":"125","author":"Naderi","year":"2012","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ihj.2024.01.006_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/ijem.ijem_120_21","article-title":"Impact of adherence, patient perception, and Knowledge to statin therapy - a cross-sectional study","volume":"25","author":"Umarje","year":"2021","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.ihj.2024.01.006_bib10","article-title":"Adherence and persistence among statin users aged 65 years and over: a systematic review and meta-analysis","author":"Ofori-Asenso","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"10.1016\/j.ihj.2024.01.006_bib11","first-page":"459","article-title":"Is there a relationship between early statin compliance and a reduction in healthcare utilization?","volume":"16","author":"Aubert","year":"2010","journal-title":"Am J Manag Care"},{"issue":"3 Suppl","key":"10.1016\/j.ihj.2024.01.006_bib12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2014.03.003","article-title":"NLA Task Force on statin safety \u2014 2014 update","volume":"8","author":"Jacobson","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"44","key":"10.1016\/j.ihj.2024.01.006_bib13","first-page":"748","article-title":"Treatment options for statin-associated muscle symptoms","volume":"112","author":"Laufs","year":"2015","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"10.1016\/j.ihj.2024.01.006_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejim.2014.12.014","article-title":"Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes","volume":"26","author":"Gencer","year":"2015","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.ihj.2024.01.006_bib15","first-page":"e133","article-title":"Primary nonadherence to statin therapy: patients' perceptions","volume":"19","author":"Harrison","year":"2013","journal-title":"Am J Manag Care"},{"issue":"2","key":"10.1016\/j.ihj.2024.01.006_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacl.2017.02.013","article-title":"Attitudes and actions: a survey to assess statin use among Finnish patients with increased risk for cardiovascular events","volume":"11","author":"Silvennoinen","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ihj.2024.01.006_bib17","article-title":"Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients","author":"Nihar","year":"2023","journal-title":"Clinical Cardiology, Volume46, Issue1"},{"issue":"7","key":"10.1016\/j.ihj.2024.01.006_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011765","article-title":"Patient-reported reasons for declining or discontinuing statin therapy: insights from the PALM registry","volume":"8","author":"Bradley","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.ihj.2024.01.006_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8953","article-title":"Assessment of beliefs and attitudes about statins posted on twitter: a qualitative study","volume":"3","author":"Golder","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ihj.2024.01.006_bib20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s11886-022-01729-x","article-title":"SAMSON and the Nocebo effect: management of statin intolerance","volume":"24","author":"Krishnamurthy","year":"2022","journal-title":"Curr Cardiol Rep"},{"issue":"8","key":"10.1016\/j.ihj.2024.01.006_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11883-020-00853-9","article-title":"Statins in a distorted mirror of media","volume":"22","author":"Nelson","year":"2020","journal-title":"Curr Atherosclerosis Rep"},{"issue":"8","key":"10.1016\/j.ihj.2024.01.006_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.11622\/smedj.2014099","article-title":"Understanding patients' perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review","volume":"55","author":"Chee","year":"2014","journal-title":"Singap Med J"},{"issue":"5","key":"10.1016\/j.ihj.2024.01.006_bib23","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cjca.2012.05.007","article-title":"Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis","volume":"28","author":"Lemstra","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ihj.2024.01.006_bib24","series-title":"Perceptions of Statins. Research with Patients, GPs and Cardiologists","author":"Bohan","year":"2015"},{"issue":"6","key":"10.1016\/j.ihj.2024.01.006_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.13186","article-title":"Cardiovascular outcomes and mortality associated with discontinuing statins in older patients receiving polypharmacy","volume":"4","author":"Rea","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483224000063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483224000063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T01:38:27Z","timestamp":1712626707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483224000063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":25,"alternative-id":["S0019483224000063"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2024.01.006","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non adherence to lipid-lowering therapy and strategies to improve adherence","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2024.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier, a division of RELX India, Pvt. Ltd on behalf of Cardiological Society of India.","name":"copyright","label":"Copyright"}]}}